QNCX
#4410
Quince Therapeutics, Inc. - Common Stock
33.7 5 USD
+0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.85%
Monthly Change
+54.75%
6 month change
+30581.82%
Year Change
+1970.55%
Previous Close
32.5 0
Open
33.7 5
Low
33.7 5
High
33.7 5
Volume
2
Financials
- Market Capitalization 34.33 M
- Employee 38
- Founded 2012
- CEO N/A
- Website www.quincetx.com
- Headquarter California, United States
- FIGI BBG00BTK1DT8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.99
Price to sales ratio
351.83
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4390 |  OABIW OmniAb, Inc. - Warrant | 0.2500 USD | 0.00% | +6.88% | +454.32% | +80.51% | 36.35 M USD | ||
| 4405 |  CNTX Context Therapeutics Inc. - Common Stock | 0.38 USD | -9.52% | -22.45% | -38.71% | -55.29% | 34.91 M USD | ||
| 4418 |  LITS Lite Strategy, Inc. - Common Stock | 0.98 USD | -2.00% | -4.85% | +3.16% | -67.11% | 33.34 M USD | ||
| 4430 |  KYNB Kyntra Bio, Inc. - Common Stock | 8.02 USD | +0.25% | +4.56% | +16.57% | -15.67% | 32.47 M USD |
Frequently asked questions about Quince Therapeutics, Inc. Common Stock
What is the Quince Therapeutics, Inc. Common Stock stock price today?
The current price of Quince Therapeutics, Inc. Common Stock (QNCX) is 33.75. Over the past 24 hours, the stock has changed by +3.85%. Follow the QNCX chart for real-time price dynamics.
What is the stock ticker of Quince Therapeutics, Inc. Common Stock?
Quince Therapeutics, Inc. Common Stock trades under the ticker QNCX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Quince Therapeutics, Inc. Common Stock stock going up?
QNCX has changed by +2.27% over the last week, +54.75% over the last month, and +1970.55% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Quince Therapeutics, Inc. Common Stock?
Quince Therapeutics, Inc. Common Stock currently has a market capitalization of 34.33 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Quince Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Quince Therapeutics, Inc. Common Stock reported earnings of -12.31 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Quince Therapeutics, Inc. Common Stock revenue for the last quarter?
Quince Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Quince Therapeutics, Inc. Common Stock net income for the last quarter?
Quince Therapeutics, Inc. Common Stock reported net income of -75.49 M for the last quarter. The previous quarter showed 35.91 M, which means net income changed by -310.20%.
How many employees does Quince Therapeutics, Inc. Common Stock have?
As of the latest available data, Quince Therapeutics, Inc. Common Stock has 38 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Quince Therapeutics, Inc. Common Stock stock?
You can buy Quince Therapeutics, Inc. Common Stock (QNCX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Quince Therapeutics, Inc. Common Stock stock?
Investing in Quince Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the QNCX chart and related analysis on metatrader.com as part of your research.